On second exposure, she experienced immediate anaphylaxis 30 min into infusion.<h4>Conclusion</h4>Our case illustrates the importance of heightened awareness by physicians that type I IgE-mediated reactions after first exposure to monoclonal antibodies such as rituximab are possible, and if unrecognized, could be potentially life-threatening. Here, IGHE is linked to anaphylaxis.